{"disease":{"id":"savi","name":"savi"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02974595","title":"Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)","phase":"","overall_status":"RECRUITING","enrollment_count":3200,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04301440","title":"THE PHYSIOLOGICAL EFFECTS OF ELECTROMAGNETIC EMISSIONS ON THE GENERAL CONDITION OF THE PATIENT","phase":"NA","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Clinique Bizet","has_results":false},{"nct_id":"NCT01724580","title":"Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Eli Lilly and Company","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}